Dr. Agarwal’s Group of Eye Hospitals CEO Adil Agarwal and Chairman Amar Agarwal pronounces contemporary spherical of funding from global investors.
| Photo Credit: Special Arrangement
Dr Agarwal’s Health Care Ltd (DAHCL) has raised ₹650 crore from current global investors TPG Growth and Singapore-based Temasek to double its hospital community to 300 within the subsequent three years.
“With in a span of 12 months, global investors have invested ₹1,050 crore and ₹650 crore in two tranches in our company,” Dr. Agarwal’s Group of Eye Hospitals Chairman Amar Agarwal stated throughout an interplay.
“We will be spending more than ₹1,200 crore to set up hospitals across India and Africa and for acquiring latest technologies for super-speciality eyecare.”
The city-based firm has over 150 centres and it plans to double it to 300 within the subsequent three years. It has new tasks developing in Mumbai, Punjab, Tamil Nadu, Gujarat, Maharashtra and Kerala.
“We have strong presence in most of the states. But nil presence in New Delhi, NCR, Uttar Pradesh, Bihar and Uttarakhand. We are in talks with 20-25 parties to acquire their small hospitals or chains.
Asserting that the expansion would be a mix of both greenfield and brownfield, he said: “We prefer brownfield in new geographies as it is easier to scale up faster. Moreover, it comes with in-built facility, staff and doctors.”
DAHCL has its presence in 10 African operations. It is planning to enter Nigeria and Democratic Republic of the Congo that might enhance its presence from the present 15 to 50.
The firm ended FY22 with a turnover of ₹1,050 crore and FY23 with ₹1,500 crore. It is aiming to the touch ₹2,500 crore by FY26, stated CEO Adil Agarwal.
“Plans are on to take the total number of Dr. Agarwal’s Eye Clinic to 100 from the present 12 in three years. These primary eye clinics will come up in tier-2 and 3 towns,” Mr. Adil stated.
